Analytical validation of the Immunoscore and its associated prognostic value in patients with colon cancer.
Florence MarliotXiaoyi ChenAmos KirilovskyThomas SbarratoCarine El SissyLuciana BatistaMarc Van den EyndeNacilla Haicheur-AdjouriMaria-Gabriela AniteiAna-Maria MusinaViorel ScripcariuChristine Lagorce-PagèsFabienne HermitteJérôme GalonJacques FieschiFranck PagèsPublished in: Journal for immunotherapy of cancer (2021)
IS is a robust and validated clinical assay leveraging immune scoring to predict recurrence risk of patient with localized colon cancer. The strong and independent prognostic value of IS should pave the way for it use in clinical practice.